Stockwinners Market Radar for October 25, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:04 EDT Cathie Wood's ARK Investment bought 311K shares of Verve Therapeutics today

18:43 EDT Asana CEO buys $2.16M in common stock - In a regulatory filing, Asana disclosed that its CEO Dustin Moskovitz bought 123.5K shares of common stock on October 23rd in a total transaction size of $2.16M.

18:02 EDT S&T Bancorp raises quarterly dividend 6.5% to 33c per share - The Board of Directors of S&T Bancorp approved a 33c per share cash dividend on October 25, 2023. This is an increase of 2c, or 6.5%, compared to a cash dividend of $0.31 per share declared in the same period in the prior year. The annualized yield using the October 24, 2023 closing price of $24.99 is 5.3%. The dividend is payable November 24, 2023 to shareholders of record on November 9, 2023.

17:45 EDT Amazon introduces AI-powered image generation to help advertisers - The Amazon staff blogged in part earlier on wednesday: "...Producing engaging and differentiated creatives can increase cost and often requires introducing additional expertise into the advertising process," said Colleen Aubrey, senior vice president of Amazon Ads Products and Technology...At Amazon Ads, we are always thinking about ways we can reduce friction for our advertisers, provide them with tools that deliver more impact while minimizing effort, and ultimately, deliver a better advertising experience for our customers... To that end, Amazon Ads has launched image generation in beta-a generative AI solution designed to remove creative barriers and enable brands to produce lifestyle imagery that helps improve their ads' performance...In the Amazon Ad Console, advertisers simply select their product and click Generate, with the tool leveraging generative AI to deliver a set of lifestyle and brand-themed images, based on product details, in a matter of seconds." Reference Link

17:28 EDT Alnylam announces publication of results from Phase 3 study of patisiran - Alnylam announced results from the APOLLO-B Phase 3 study of investigational patisiran in patients with the cardiomyopathy of transthyretin-mediated - ATTR - amyloidosis published online in the New England Journal of Medicine. The data reported in the APOLLO-B Phase 3 study publication demonstrate that patisiran, an RNAi therapeutic targeting transthyretin - TTR -, preserved functional capacity and health status and quality of life compared with placebo at 12 months. In addition, treatment with patisiran demonstrated favorable effects on biomarkers of cardiac stress and injury and on measures of cardiac structure and function. The Phase 3 study achieved its primary endpoint at 12 months, with patisiran demonstrating a significant difference in the change from baseline in functional capacity compared with placebo. The study also met its first secondary endpoint, with patisiran demonstrating a significant difference in the change from baseline in health status and quality of life compared with placebo. For the composite endpoint of all-cause mortality, frequency of cardiovascular events, and change from baseline in 6-MWT over 12 months compared with placebo, the win ratio favored patisiran but did not reach statistical significance. Patisiran demonstrated an encouraging safety and tolerability profile in the APOLLO-B Phase 3 study, including no cardiac safety concerns relative to placebo, through 12 months. The majority of adverse events were mild or moderate in severity.

17:19 EDT Veralto to initiate 9c per share dividend - The Company intends to initiate a quarterly cash dividend of $0.09 per common share in arrears commencing following the quarter ending December 31, 2023, subject to approval by its Board of Directors with respect to each such dividend.

17:12 EDT Methanex saw 'improving global market conditions' through Q3 - The company states: "Our average realized price in the third quarter was $303 per tonne compared to $338 per tonne in the second quarter of 2023. Through the third quarter we saw improving global market conditions with stronger demand as well as moderation in global operating rates mainly from various supply outages in North America, the Middle East and Southeast Asia. We expect actual production for 2023 to be slightly above 2023 production guidance of approximately 6.5 million equity tonnes, excluding any production from G3. Actual production may vary by quarter based on timing of turnarounds, gas availability, unplanned outages and unanticipated events."

17:06 EDT Marathon Petroleum raises quarterly dividend 10%, announces $5B share buyback - The board of directors of Marathon Petroleum has declared a dividend of 82.5c per share on common stock, an increase of approximately 10% over its previous dividend of 75c per share. The dividend is payable Dec. 11, 2023, to shareholders of record as of the close of business Nov. 16, 2023. Additionally, the board of directors of MPC has approved an additional $5B share repurchase authorization. This authorization is in addition to its previous authorization, which had approximately $4.3B remaining as of September 30. The authorization has no expiration date.

17:05 EDT Endeavor Group jumps 20% to $21.29 on Silver Lake take-private report

17:03 EDT West Fraser Timber sees 2023 total lumber shipments 'similar' to 2022 levels - "We continue to expect total lumber shipments in 2023 will be largely similar to 2022 levels since we have not experienced in 2023 the type of severe transportation challenges faced last year, though this has been partially offset by the permanent B.C. mill curtailments announced in August 2022 and the indefinite curtailment of the Perry, Florida sawmill announced in January 2023. However, while we are reiterating our 2023 SPF shipments guidance of 2.6 to 2.8 billion board feet, market demand in the U.S. South has begun to show signs of cooling and as such we now expect 2023 SYP shipments to be at the bottom end of our 2.9 to 3.1 billion board feet guidance range. In our NA EWP segment, demand has remained relatively robust and as such we are reiterating our 2023 OSB shipments guidance of 6.1 to 6.4 billion square feet (3/8-inch basis). Our modernization capital investment in Allendale, South Carolina is now effectively complete as the start-up phase of the mill, which began in late Q2-23, progresses in-line with expectations. We anticipate a ramp-up period of up to three years to meet targeted production and as such we do not anticipate the Allendale mill contributing materially to shipments in 2023. In our Europe EWP segment, we expect near-term demand weakness to continue and thus expect 2023 OSB shipments to be near the bottom end of the guidance range of 1.0 to 1.2 billion square feet (3/8-inch basis). In the Pulp & Paper segment, activities in respect of the closing conditions for the previously announced sale of Hinton pulp mill are proceeding and we now anticipate closing the transaction in early 2024. Activities in respect of the closing conditions for the sale of Quesnel River Pulp mill and Slave Lake Pulp mill are proceeding and we anticipate closing of the transaction in early 2024. In Q3-23, we experienced continued moderation of costs and improved availability for inputs across our supply chain, including resins, chemicals, transportation and energy, although labour availability and some capital equipment lead times remained challenging. We expect these trends to largely continue over the near term. Based on our current outlook and owing to lengthened lead times for projects underway or planned, we anticipate that there will be a carryover of capital spending into 2024 for projects in progress, and as such we now expect to invest approximately $450 million in 2023."

16:56 EDT Align Technology falls 22% to $199.01 after Q3 earnings miss, FY23 guidance cut

16:53 EDT Veris Residential raises 2023 SSS view to up 9%-10% from up 4%-6%

16:52 EDT ATN International sees FY24 adjusted EBITDA $200M-$208M - Capital expenditures for the full year 2024 expected to be in the range of $120 to $130M. "As we move closer to the final year of our three-year schedule of investments, we are planning to come down the other side of the investment bell curve, positioning us to start to reap the benefits of our network investments more fully. These expected benefits include growth in our subscriber base, revenue, and operating margins alongside reduced capital expenditures, as reflected in our full-year 2024 preliminary outlook," noted management.

16:50 EDT IBM up 2% at $140.00 after Q3 earnings beat, maintained revenue growth outlook

16:43 EDT Tronox co-CEO Jean-Francois Turgeon to retire, John Romano to be sole CEO - Tronox Holdings announced that Jean-Francois Turgeon, Tronox's co-CEO, will retire from Tronox on April 1, 2024. John Romano, current co-CEO, will become Tronox's sole CEO effective as of Turgeon's retirement. The Board of Directors intends to nominate Turgeon for reelection as a Board member at the company's Annual General Meeting in May 2024.

16:41 EDT Ultra Clean closes acquisition of HIS Innovations Group - Ultra Clean Holdings announced that it has closed the acquisition of HIS Innovations Group, a privately held company based in Hillsboro, Oregon. HIS is a leading supplier to the semiconductor sub-fab segment including the design, manufacturing, and integration of components, process solutions, and fully integrated sub-systems. UCT anticipates the acquisition to be accretive to shareholders on an adjusted basis. The HIS team will continue to be based in Hillsboro and will report into UCT's Products division.

16:37 EDT Luxfer initiates strategic review process - The company said, "As was also announced on October 11, Luxfer is accelerating and expanding its annual strategic review process, with the goal of driving improved financial performance and identifying opportunities to maximize value. To support its efforts and to ensure a rigorous, independent review, the Board of Directors has engaged a leading global investment bank to assist the Company in conducting a comprehensive process to thoroughly evaluate all of Luxfer's businesses, its capital structure, and available alternatives to unlock and maximize value. The comprehensive strategic review is ongoing, and the Company plans to provide an update on or before its fourth quarter and full year 2023 earnings call to be held in February 2024."

16:35 EDT Sirius XM raises quarterly cash dividend 10% to 2.66c per share - SiriusXM announced that its Board of Directors declared a quarterly cash dividend of 2.66c per share of common stock, reflecting an increase of approximately 10% over the previous quarter's dividend. This regular quarterly dividend is payable in cash on November 29 to stockholders of record at the close of business on November 7.

16:33 EDT Idex Corp. names Abhi Khandelwal CFO - IDEX Corporation announced the appointment of Abhi Khandelwal as Senior Vice President and Chief Financial Officer of the Company, effective November 20, 2023. Mr. Khandelwal returns to IDEX where he served from 2010 to early 2020 in a number of financial roles of increasing responsibility, most recently as Vice President of Finance Operations, Treasury and Financial Planning & Analysis. He joins IDEX after serving as Chief Financial Officer of Multi-Color Corporation, a global packaging services and label solutions provider based in Rosemont, Illinois since January 2022, and, prior to that, as Senior Vice President and Chief Financial Officer for CIRCOR International. Prior to his initial service with IDEX, Mr. Khandelwal held a range of financial leadership positions at Stanley Black & Decker and General Electric. He earned a Bachelor of Science degree in Finance from Indiana University and a Master of Business Administration degree from Northwestern University. "We are thrilled to welcome Abhi back to IDEX, where he will be able to leverage his CFO experience along with his successful prior history with our organization and our people. He was a trusted financial partner to me in my earlier role as COO, and I look forward to his expertise and partnership in helping IDEX continue to grow," IDEX CEO and President Eric Ashleman said.

16:28 EDT Meta Platforms up 4% to $312.01 after Q3 earnings - Meta shares are up $12.48, or 4%, to $312.01 in after-hours trading ahead of the company's earnings call.

16:25 EDT Rocket Lab receives FAA authorization to resume launches - Rocket Lab USA announced it has received authorization from the Federal Aviation Administration to resume Electron launches from Launch Complex 1. The authorization comes after Rocket Lab experienced an in-flight anomaly on September 19th during the Company's 41st Electron launch. The FAA, the federal licensing body for U.S. launch vehicles, has now confirmed that Rocket Lab's launch license remains active, which is the first step to enable launches to resume. Rocket Lab is now finalizing a meticulous review into the anomaly's root cause, a process that involves working through an extensive fault tree to exhaust all potential causes for the anomaly, as well as completing a comprehensive test campaign to recreate the issue on the ground. The FAA is providing oversight of Rocket Lab's mishap investigation to ensure Rocket Lab complies with its FAA-approved mishap investigation plan and other regulatory requirements. In addition, the National Transportation Safety Board (NTSB) was granted official observer status to the investigation. The full review is expected to be completed in the coming weeks, with Rocket Lab currently anticipating a return to flight later this quarter with corrective measures in place. During the September 19th mission, Electron completed a successful lift-off, first stage burn and stage separation as planned, before an issue was experienced at around two and a half minutes into flight shortly after second stage engine ignition. Flight data shows Electron's first stage performed as expected during the mission and did not contribute to the anomaly.

16:22 EDT Nextracker announces plan to separate fromFlex - Nextracker (NXT) "announced Flex Ltd.'s (FLEX) plan to effect a spin-off of all of its remaining interests in Nextracker Inc. to Flex shareholders, which would result in a separation by Flex from its ownership in Nextracker. Later today, Nextracker expects to file a registration statement on Form S-4 with the U.S. Securities and Exchange Commission, that includes a preliminary proxy statement of Flex, which will include additional information regarding the spin-off. The separation from Flex is currently expected to close in fiscal Q4 ending March 31, 2024, but remains subject to a number of conditions, and no assurance can be given that the spin-off will in fact occur."

16:20 EDT Meta reports Facebook DAUs 2.09B on average for September, up 5% year-over-year

16:17 EDT Solo Brands names Andrea Tarbox interim CFO - Solo Brands announced that Somer Webb, Chief Financial Officer, has notified the Company of her intent to pursue other opportunities. Ms. Webb will remain with the Company until December 10, 2023. The Company has engaged an executive search firm to assist in identifying her successor. The Company has also announced Andrea Tarbox will assume the role of Interim CFO beginning on December 10, 2023. Tarbox serves on the board of directors of Solo Brands and chairs the audit committee.

16:14 EDT ServiceNow jumps 6% to $563 after Q3 earnings beat

16:14 EDT ServiceNow sees FY23 subscription revenue growth of 25%

16:09 EDT Amerisafe declares special dividend of $3.50 per share - The special cash dividend will be payable on December 15, 2023 to shareholders of record as of December 1, 2023.

16:06 EDT Sunnova Energy sees FY24 adjusted EBITDA $350M-$450M - Sees FY24 customer additions 185,000-195,000.

16:04 EDT Choice Hotels calls on Wyndham Hotels & Resorts to engage in merger talks - Choice Hotels International (CHH) called upon the board of directors of Wyndham Hotels & Resorts (WH) to engage in good faith discussions so that shareholders of both companies can benefit from the compelling combination. Patrick Pacious, President and Chief Executive Officer of Choice, said, "We appreciate the positive feedback we have received since first making our proposal public, particularly the support from both companies' shareholders and franchisees. Through our conversations with these stakeholders, we are encouraged by their clear understanding of the natural fit of the two businesses and belief in the combined company's ability to drive greater shareholder returns, franchisee profitability, and strategic benefits. They, and others, share our perspective that a transaction is pro-competitive, has a clear path to completion, and creates a combined company with a strong free cash flow profile to support both rapid deleveraging and investments for growth." Pacious continued, "We respect Wyndham's desire to achieve the best outcome for its shareholders, but that can't happen if Wyndham unilaterally ends our discussions. Both companies' shareholders have expressed to us their understanding of the tremendous value this combination could deliver. As recently as a few weeks ago, Wyndham prepared a critical information request list, on which both parties broadly aligned, to help Choice and Wyndham close any remaining value gaps. Wyndham then disengaged before any information was exchanged. We therefore strongly urge Wyndham to return to the discussions. Choice is ready to move expeditiously to negotiate binding terms, including mechanisms to provide market standard protections for Wyndham shareholders."

16:01 EDT Lennox acquires AES - Lennox has completed the acquisition of AES, a company dedicated to service and sustainability in the light commercial market. Across North America, AES provides installations services, adapter curbs, and reclaim services. AES will become part of the Lennox Commercial Business Segment and enable the delivery of "front-to-back" life-cycle integrated services to AES and Lennox customers. AES President Jason Benton will join the Lennox Commercial business segment in a leadership role and will continue to lead the AES business and team of approximately 280 associates. Terms of the acquisition were not disclosed.

15:47 EDT CSX announces ratification of paid sick leave pact covering 200 BRS workers - CSX Corp. is announcing the ratification of a paid sick leave agreement covering approximately 200 employees represented by the Brotherhood of Railroad Signalmen, or BRS, on the company's L&N property. "The ratification follows another recent agreement with the BRS covering nearly 400 employees on the SCL property. Both agreements provide a sick leave package that ensures employees can take necessary time off from work to recover from illness without worrying about their financial stability," the company said.

15:02 EDT Payoneer announces collaboration with Etsy - Payoneer (PAYO) announced a collaboration with Etsy (ETSY) to support its bespoke seller offering, Etsy Payments. "The collaboration will enable Etsy to streamline payments to sellers and help create economic opportunities to more entrepreneurs in emerging markets. Etsy Payments is the core of Etsy's payment technology and enables flexible and secure payments infrastructure to both buyers and sellers. The collaboration between Payoneer and Etsy will utilize Payoneer's global infrastructure to offer greater services and seamless payouts to sellers in the currency of their preference. It will initially be launched in Ukraine and Thailand, followed by India, Japan, Argentina, Chile, and Peru by the end of 2023," the company stated. Ya Wen, SVP Americas at Payoneer, commented: "As a leader in cross-border financial services technology, Payoneer will provide critical infrastructure to support Etsy in expanding its payments offering to sellers in emerging markets and navigating complex payment ecosystems. This collaboration will help create opportunities for the often-underserved sellers in emerging markets, giving them better access to global demand. We are delighted to be working with such an established brand. We look forward to working with Etsy to increase accessibility for sellers in other markets."

14:36 EDT Abbott announces late-breaking data from LIFE-BTK clinical trial - Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK Everolimus Eluting Resorbable Scaffold System in people with chronic limb-threatening ischemia. CLTI is a severe stage of peripheral artery disease due to advanced arterial blockage in the lower extremities. The LIFE-BTK trial met both of its primary safety and effectiveness endpoints, demonstrating that Esprit BTK reduces disease progression and helps improve medical outcomes compared to the current standard of care, balloon angioplasty. Data from LIFE-BTK was presented as a late-breaking clinical trial at the 35th Transcatheter Cardiovascular Therapeutics Conference in San Francisco and simultaneously published in the New England Journal of Medicine. The LIFE-BTK trial enrolled 261 people worldwide. The study aimed to investigate whether Esprit BTK could offer greater benefits than the current option of balloon angioplasty to open blocked arteries in the leg and to keep the arteries open. The trial's primary efficacy endpoint evaluated primary patency plus limb salvage. The trial met the efficacy endpoint and showed that Esprit BTK is superior to balloon angioplasty in lowering the risk of total obstruction of the target vessel, narrowing of the target lesion, major amputation and repeat interventions of the target lesion. The primary safety endpoint evaluating freedom from above-the-ankle amputation, major reintervention at six-months and death within 30-days showed that Esprit BTK was non-inferior to balloon angioplasty. Based on the strength of the LIFE-BTK trial results, Abbott intends to submit the Esprit BTK Everolimus Eluting Resorbable Scaffold System for review by the U.S. Food and Drug Administration.

14:35 EDT Boston Scientific reports 'positive' 12-month results from AGENT IDE trial - Boston Scientific announced "positive" 12-month results from the pivotal AGENT IDE clinical trial of the AGENT Drug-Coated Balloon, or DCB. Primary endpoint findings from this first clinical trial in the U.S. to evaluate the safety and effectiveness of using a DCB to treat coronary in-stent restenosis, or ISR, were presented in a late-breaking clinical trial session at Transcatheter Cardiovascular Therapeutics, the annual scientific symposium of the Cardiovascular Research Foundation, the company said. This trial met the primary endpoint of target lesion failure at 12 months with the AGENT DCB demonstrating statistical superiority to uncoated balloon angioplasty. These differences were mainly driven by significantly reduced rates of myocardial infarction related to the target vessel, TV-MI, or heart attack, and the need for a target lesion revascularization, TLR, or a repeated percutaneous coronary intervention, procedure. Overall, data demonstrated an approximate 38% relative risk reduction in TLF, the company stated.

14:20 EDT Ree Automotive says order book has doubled since August to $40M - Ree Automotive announced its initial order book value has doubled since late August. Ree's initial order book value is now approximately $40M with a recent binding order by Midwest Transit Equipment. "As we are close to delivering our first vehicles in the US market, REE continues to see strong demand for our P7 electric trucks from dealers around North America, resulting in our order book value doubling in just under two months," said Tali Miller, chief business officer at Ree. "We are excited to be chosen by Midwest Transit Equipment, a leading bus dealer in the US, as they enter the medium duty truck segment."

13:21 EDT Farmers & Merchants appoints Barbara Britenriker as CFO - F&M Bank, an Archbold, Ohio-based community bank owned by Farmers & Merchants Bancorp, announced several organizational changes to achieve strategic goals and ambitions for the future of the organization. Barbara Britenriker, EVP/Chief Financial Officer for F&M Bank and Farmers & Merchants Bancorp: As Chief Financial Officer for both F&M Bank and Farmers & Merchants Bancorp, Inc., Barb will lead the redesign of the Company's finance capabilities to support a bank with $5 billion in total assets. Her expanded focus will be on financial reporting, cash management, financial systems, and investor relations. Katrina DeGroff, SVP/Chief Accounting Officer: As Chief Accounting Officer, Katrina will be accountable for all financial reporting on Farmers & Merchants Bancorp, Inc. and its subsidiaries, as well as valuation, verification, and strategic planning initiatives. Andrew Baker, SVP/Chief Retail Banking Officer and Regional President of Northern Indiana: In his expanded role, Andy will be responsible for leading all aspects of F&M's community-based retail bank operations, including the Company's branch network, mortgage line of business and private banking. He will retain his position as Regional President of Northern Indiana. Taryn Marino, SVP/Deputy Chief Retail Banking Officer: As the Deputy Chief Retail Banking Officer, Taryn will report to Andy supporting the strategic goals of F&M's retail banking operations. Taryn will have a direct impact on implementing strategies to achieve growth, profitability, and operational efficiency, while enhancing F&M's customer experience.

12:43 EDT Accenture to acquire Stagwell's ConcentricLife - Accenture (ACN) has agreed to acquire ConcentricLife, a healthcare marketing agency with expertise in helping Life Sciences brands build an optimal brand experience at any stage of the health journey. The agreement to acquire ConcentricLife, which is a subsidiary of Stagwell (STGW), "reinforces Accenture Song's continued investment in creating end-to-end solutions for its Life Sciences clients through relevant communications and experiences attuned to the ever-evolving lives of today's patients and healthcare professionals," the company stated. Headquartered in New York, ConcentricLife's 270+ employees will join Accenture Song in other markets including Atlanta, Chicago, Ft. Lauderdale, San Diego and London. Completion of the acquisition is subject to customary closing conditions, including receipt of regulatory clearance.

12:30 EDT SeqLL Inc trading halted, volatility trading pause

12:01 EDT Greenbrier falls -14.1% - Greenbrier is down -14.1%, or -$5.76 to $35.10.

12:00 EDT Enova International falls -18.3% - Enova International is down -18.3%, or -$8.10 to $36.08.

12:00 EDT Stride rises 17.7% - Stride is up 17.7%, or $7.86 to $52.36.

11:13 EDT Jaguar Global Growth Corporation I trading resumes

11:09 EDT Boeing sees updating guidance for 2024 in early part of year

11:07 EDT LifeVantage calls Radoff-Sudbury Group's allegations 'simply false' - LifeVantage issued the following statement in response to a press release issued by Bradley Radoff and Sudbury Capital Fund: "LifeVantage did not compensate any consultant for providing a statement to the media regarding the consultants' perspectives on LifeVantage's strategy, Board of Directors and leadership team. The nearly 300 consultants who signed the statement in support of the Company -who are responsible for over 80% of the Company's net revenue - did so voluntarily, independently and without any compensation. LifeVantage took no part in drafting the consultants' statement. The Radoff-Sudbury Group's allegations to the contrary are simply false."

11:01 EDT FedEx provides updates on weather, other service disruptions - FedEx Express experienced disruptions at the Memphis hub last night due to an FAA IT system outage. Potential delays are possible for package deliveries across the U.S. with a delivery commitment of October 25, 2023. Contingency plans are in place and FedEx is committed to providing service to the best of our ability. The company also said FedEx International inbound and outbound service to and from Israel has been reinstated. Pick-up and delivery services will be performed according to local authority instructions, where it is safe and possible. Regarding Maui wildfires, the company said, " we appreciate your patience as we continue to experience delays due to the heightened impacts of the fires." Service delays and disruptions can be anticipated for inbound and outbound shipments throughout the following ZIP Codes: 96761 and 96767. Lastly, FedEx noted that all Russian and Belarusian FedEx International services have been suspended until further notice. As previously communicated, locations in Ukraine have been temporarily closed and inbound and outbound services to Ukraine have been temporarily suspended.

10:53 EDT Biogen says Phase 1b data on BIIB080 in Alzheimer's showed 'favorable trends' - Biogen (BIIB) reported new Phase 1b clinical data from the study of BIIB080, an investigational antisense oligonucleotide, or ASO, therapy targeting tau, in mild Alzheimer's disease, or AD. "The data showed favorable trends on multiple exploratory endpoints of cognition and activities of daily living in AD, building upon prior results which showed a reduction of tau protein in the cerebral spinal fluid and tau positron emission tomography across brain regions," the company stated. The late-breaking results were presented at the 2023 Clinical Trials on Alzheimer's Disease, or CTAD, meeting held in Boston, MA from October 24-27. "This is the first time we've seen both strong target engagement and favorable trends on clinical outcomes with a novel mechanism targeting tau. While these are preliminary findings, we are excited about these results and continue to enroll the Phase 2 CELIA study. We believe defeating Alzheimer's disease will take different approaches and we are committed to exploring the targeting of tau as a new generation of treatment," said Priya Singhal, M.D., M.P.H., Head of Development at Biogen. Recruitment for the Phase 2 CELIA study, evaluating the potential for this ASO targeting tau to slow the worsening of mild cognitive impairment or mild dementia due to AD, is ongoing at sites across North America, Europe and Asia Pacific. In December 2019, Biogen exercised a license option with Ionis (IONS) and obtained a worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB080, the company noted.

10:49 EDT Twin Ridge Capital Acquisition Corp trading halted, volatility trading pause

10:48 EDT Kroger announces acceptance of EBT payments for digital Pickup, Delivery - The Kroger Co. now accepts EBT payment for digital Pickup and Delivery orders across Kroger Family of Stores, expanding customer access to fresh, healthy foods under the Supplemental Nutrition Assistance Program.

10:40 EDT ASPAU Stock trading resumes

10:38 EDT Boeing 'encouraged' by signs of progress regarding future China Max deliveries

10:36 EDT Boeing seeing increased stability in factories, says CEO

10:34 EDT Boeing still sees 2025/2026 target of $10B in free cash flow

10:19 EDT Muddy Waters says short Sunrun on 'greatly exaggerated' subscriber numbers - In a recently published report, Muddy Waters said it is "again short Sunrun" as it now believes Sunrun has "greatly exaggerated its Subscriber numbers for years, with the current overstatement seemingly close to five quarters of reported deployments. It appears that Sunrun has been claiming and selling tax credits on these inflated numbers as well. The amount of possible excess tax credits for 2022 alone could be ~$200 million." Overall, Muddy Waters' cites "likely substantially inflated per subscriber value, seemingly greatly inflated number of subscribers, possible ITC issues, and dumpster fire financials." Sunrun's stock had dropped about 9% to $8.81 in Wednesday morning trading. Reference Link

10:12 EDT NYAX Stock trading halted, volatility trading pause

10:07 EDT Apple boosts price of Apple TV+ service to $9.99 per month from $6.99 - Apple is raising the price of its Apple TV+ service to $9.99 per month from $6.99, the company said on its website. It is also raising the price of Arcade to $6.99 from $4.99, and news to $12.99. Price increases for existing users will be effective in 30 days. Reference Link

10:06 EDT UNLMTD Real Estate, FIAT partner for FIAT House concept - UNLMTD Real Estate and FIAT announced their partnership in the creation of FIAT House. FIAT House is an innovative residential property featuring over 300 rental residences with hospitality-driven amenities, tailored concierge services, and unique community events, set to open in early 2024. FIAT House is situated at the foot of the George Washington Bridge in Fort Lee, New Jersey, just moments away from Manhattan. Nestled at the convergence of eight major highways and offering access to multiple mass-transit and alternative transportation options, FIAT House will provide residents with unmatched accessibility to New Jersey, New York, and the rest of the world. FIAT House will represent the next generation of mobility with an onsite car-sharing fleet of all-electric FIAT 500e vehicles that will provide residents with a fun-to-drive and sustainable mobility solution.

10:00 EDT Lumen, Zoom Video expand partnership for phone services - Lumen Technologies (LUMN) has expanded its partnership with Zoom (ZM) to create a simple, secure way for businesses to collaborate anywhere, anytime. This benefits businesses of all sizes by combining Lumen's reliable network infrastructure and phone services with Zoom's feature-rich cloud phone system. As part of the agreement, Lumen will provide Enhanced Local Service, Wholesale Long Distance and Wholesale Toll Free services to Zoom. This will allow Zoom to combine Lumen Public Switched Telephone Network connectivity with its cloud-based Zoom Phone offering.

10:00 EDT 3D Systems falls -16.7% - 3D Systems is down -16.7%, or -73c to $3.67.

10:00 EDT PROG Holdings rises 9.7% - PROG Holdings is up 9.7%, or $2.77 to $31.25.

10:00 EDT Stride rises 18.1% - Stride is up 18.1%, or $8.05 to $52.55.

09:48 EDT Sunrise New Energy announces $16M order for energy storage product - Sunrise New Energy announced a major milestone as it has been assigned as the supplier of anode materials for the 2.5 GW Integrated Generation, Grid, and Energy Storage project. The IGGES Project's signing ceremony took place on September 16th, with the participation of Shenzhen Zhuhai New Energy Co., Ltd., Guangxi Longyuan Power Group Corporation Limited, China Railway Construction Corporation Limited and the People's Government of Tiandong County, Baise, Guangxi, at the 20th China-ASEAN Expo and China-ASEAN Business and Investment Summit attended by Chinese Premier Li Qiang. The IGGES Project aims to achieve efficient operation of the energy system, enhance the utilization of renewable energy, reduce reliance on conventional fossil fuels, and strengthen the flexibility and reliability of the energy system. As a key component of this strategic initiative, Sunrise New Energy Materials Co., Ltd has been signed to supply 3,000 tons of anode materials.The 2.5 GW project serves as an initial pilot for the integrated 50 GW IGGES Project over the next five years. It is estimated that a total of 60,000 tons of anode materials will be provided by Sunrise for the IGGES during this period.

09:47 EDT Enova International falls -11.6% - Enova International is down -11.6%, or -$5.12 to $39.06.

09:47 EDT Robert Half rises 8.1% - Robert Half is up 8.1%, or $5.87 to $78.00.

09:47 EDT Stride rises 17.1% - Stride is up 17.1%, or $7.60 to $52.10.

09:44 EDT Innovative International Aqstn Corp trading resumes

09:41 EDT Vertiv Holdings trading resumes

09:35 EDT Abri SPAC I Inc trading resumes

09:34 EDT Data Knights Acquisition Corp trading halted, volatility trading pause

09:30 EDT ASPAU Stock trading halted, volatility trading pause

09:29 EDT Volcon enters distribution deal with Indi Imports in New Zealand - Volcon has expanded its global distribution network into New Zealand. The Company penned an exclusive distribution agreement with Powersports Import and Distribution Limited, trading as Indi Imports. Indi Imports joins a family of established specialist powersports and automotive businesses in Queenstown Lakes District, Wanaka, New Zealand.

09:22 EDT Parker-Hannifin president Lee Banks retire, COO Andrew Ross to succeed - Parker Hannifin announced that Lee C. Banks, Vice Chairman and President and a Director, will retire on December 31, 2023, after 32 years of dedicated service to the company. Andrew Ross, currently Chief Operating Officer, has been elected by the Board of Directors as President and Chief Operating Officer, effective January 1, 2024.

09:19 EDT Parker-Hannifin appoints Parmentier as Chairman of board, Williams to retire - Parker Hannifin Corporation announced that its Board of Directors has elected Jennifer Parmentier, currently Chief Executive Officer and a Director, as Chairman of the Board, effective January 1, 2024. Parmentier will succeed Thomas Williams, Executive Chairman, who will retire on December 31, 2023, as previously announced

09:19 EDT Cheesecake Factory acquires 37 acre site in Charlestown, Indiana - The Cheesecake Factory announced that it has acquired a 37 acre site in Charlestown, Indiana where it plans to develop its third bakery production facility. Once constructed, the facility will produce The Cheesecake Factory's world-famous cheesecakes and signature bakery products for its restaurants and other foodservice wholesalers, retailers and distributors, in addition to providing anticipated distribution efficiencies for the Company.

09:17 EDT General Dynamics expects 'strong orders' in Aerospace in Q4 - Expects more than 60 business jet deliveries in Q4 if it gets g700 certification from FAA. Says Aerospace total backlog up more than 72% compared to year-end 2020. Expects to deliver 10-12 fewer aircraft in 2023 than originally forecast. Sees FY23 CapEx "slightly below" 2.5% of sales. Comments taken from Q3 earnings conference call.

09:15 EDT A2Z's Cust2mate selected as smart cart supplier for Carrefour France - A2Z Smart Technologies has been selected to supply smart carts to Carrefour's Connected Cart project for its newly merged Hypermarket and Supermarket division in France, commencing with an initial delivery of 2,000 of the Company's smart shopping carts. The first phase is the delivery of 2,000 smart carts is expected in the first half of 2024 at two Carrefour hypermarket retail locations in France. The smart carts have been specially designed to meet Carrefour's specifications.

09:14 EDT Edesa Biotech announces Health Canada approval of updated trial design - Edesa Biotech announced that Health Canada has approved the company's proposal to harmonize clinical trial designs in the U.S. and Canada for an ongoing Phase 3 study of EB05. Edesa's monoclonal antibody is currently being evaluated as a treatment for Acute Respiratory Distress Syndrome, a life-threatening form of respiratory failure characterized by widespread inflammatory injury to the lungs. Approximately 10% of all ICU admissions are ARDS related. The harmonized protocol calls for treatment of approximately 600 ARDS subjects hospitalized with SARS-CoV2 infections who are on invasive mechanical ventilation, both with and without additional organ support such as extracorporeal membrane oxygenation. The primary endpoint is the mortality rate at 28 days. The amended study design replaces the previous protocol which targeted a population of more than 800 subjects, with two independent cohorts and cohort-specific endpoints. Earlier this year, Edesa and the U.S. Food and Drug Administration agreed on the primary efficacy endpoint and single, smaller population for the Phase 3 study. Par Nijhawan, MD, Chief Executive Officer of Edesa Biotech said that having a single, harmonized protocol in the U.S. and Canada will facilitate enrollment, trial management and data analysis. Paridiprubart is a first-in-class monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. This host-directed therapeutic candidate inhibits toll-like receptor 4, a key immune signaling protein that has been shown to be activated both by viruses, like SARS-CoV2 and influenza, as well as in the pathogenesis of chronic autoimmune diseases. In a Phase 2 clinical study that the company completed during the pandemic EB05 reduced mortality by 84% among critically ill patients with ARDS. A parallel in vitro study also demonstrated that paridiprubart inhibits inflammation from influenza and other pathogens. Nijhawan said that the company is also exploring various approaches to evaluate EB05 in a general, all-cause ARDS population.

09:12 EDT EnWave signs R&D license agreement with Australian university - EnWave Corporation signed a Research and Development License Agreement with a major university in Australia. The University has also committed to purchasing a 10kW Radiant Energy Vacuum dehydration machine to be used at its Brisbane campus. Under the Agreement, the University will use the REV machinery for research and development purposes to propagate REV technology with key stakeholders in the food processing industry throughout Australia to help develop innovative, premium food applications. The installation of a 10kW REV machine at the University's Brisbane campus will increase accessibility to EnWave's technology in Australia by establishing a second domestic location for product trials and demonstrations.

09:10 EDT Skechers debuts inaugural line of basketball shoes - In time for the start of the NBA season, Skechers hits the hardwood with its inaugural line of technical basketball shoes. The initial wave of Skechers Basketball shoes launching next week includes two mid-top styles-SKX Resagrip and SKX Float.

09:10 EDT Sarcos Technology appoints interim Laura Peterson as permanent CEO - Sarcos Technology and Robotics Corporation announced that the Company's interim President and Chief Executive Officer, Laura Peterson, has been appointed to serve as the Company's permanent President and Chief Executive Officer. The Company also announced that Sarcos co-founder, current director and former Chief Executive Officer, Ben Wolff, has re-joined the executive team as Executive Vice Chairman. Peterson has served as interim President and Chief Executive Officer since May 2023 and has served on the Board of Directors since September 2021. She will continue to serve on the Company's Board of Directors. Wolff led the company from 2015 to 2021 as Chairman, President, and Chief Executive Officer and has served on the Company's Board of Directors since 2015, including as Executive Chairman from December 2021 to January 2023. As part of the executive team, Wolff will help evaluate and pursue strategic business opportunities, including for the Company's Advanced Technologies Division. Under Peterson's leadership, Sarcos has significantly reduced inefficiencies, optimized operations, fostered the AI/ML business, and reduced cash usage.

09:09 EDT Oncternal Therapeutics appoints Matthew Smith to Prostate Cancer SAB - Oncternal Therapeutics announced the addition of Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board. Dr. Smith, along with the other Prostate Cancer SAB members, will help guide Oncternal's next steps in the clinical development of its novel dual-acting androgen receptor inhibitor, ONCT-534, which is currently under investigation in an ongoing Phase 1/2 clinical study, ONCT-534-101.Smith is Director of the Genitourinary Oncology Program at Massachusetts General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School.

09:08 EDT Mountain Crest Acquisition V announces listing transfer to Nasdaq Capital Market - Mountain Crest Acquisition Corp. V received approval from the Nasdaq Stock Market to transfer the listing of its securities from the Nasdaq Global Market to the Nasdaq Capital Market. The Company's common stock, units and rights will continue to trade under the symbols "MCAG," "MCAGU" and "MCAGR," respectively and trading of its common stock, units and rights will be unaffected by this transfer. This transfer will be effective as of the opening of business on October 27, 2023. As previously disclosed, the Company received notifications from Nasdaq indicating the Company failed to comply with certain continued listing requirements for the Nasdaq Global Market. Upon the transfer of the listing of the Company's securities to the Nasdaq Capital Market on October 27, 2023, each of the deficiencies will be resolved because the Company will no longer be subject to the continued listing requirements for the Nasdaq Global Market.

09:06 EDT Atlanticus announces appointment of Scott as SVP, Head of Co-Brand Partnership - Atlanticus (ATLC) announced the appointment of Khary Scott as Senior Vice President, SVP, Head of Co-Brand Partnership Development. Khary will lead all co-brand business development activities across traditional and emerging industry verticals. Khary's career in financial services spans over 20 years including roles at Capital One (COF), Fundbox, and Imprint leading business development including partner acquisition and portfolio sales.

09:04 EDT Fortinet expands Universal SASE offering - Fortinet announced the expansion of its Universal SASE offering to empower today's hybrid workforce with FortiOS everywhere. "The Fortinet operating system, FortiOS, is the industry's only enterprise-grade converged operating system able to support all SASE functions, including firewall, SD-WAN, secure web gateway, encryption/decryption, CASB, DLP, and ZTNA, whether deployed in an appliance or cloud-delivered from Fortinet," said Ken Xie, Founder, Chairman of the Board, and CEO. "This approach enables over 30 converged networking and security functions to be managed through a single console. 14 of these functions are accelerated when deployed on our new FortiASIC Security Processor 5-based FortiGate 120G SASE appliance."

08:58 EDT Nordic American Tankers reports most recent fixtures of $40K-$70K per day - The company said, "NAT is in an excellent position. Our most recent fixtures, all to major oil companies, are in the range of $40,000 to $70,000 per day. The NAT operating costs are about $9,000 per day per ship. We call ourselves a "Dividend Company". All our actions have a main goal: To maximize dividend."

08:43 EDT Vicinity Motor receives non-compliance notice from Nasdaq - Vicinity Motor has received a notification letter from the Nasdaq Stock Market dated October 24, 2023, notifying the Company that due to its closing bid price being below $1.00 per share for 30 consecutive days, it is not in compliance with the minimum bid price requirement as set forth under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ. This press release is issued pursuant to NASDAQ Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification. In accordance with the NASDAQ Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until April 22, 2024, to regain compliance with NASDAQ Listing Rule 5550(a)(2). To regain compliance, the Company's shares must have a closing bid price of at least $1.00 for a minimum of 10 consecutive business days, at which point the matter will be closed. In the event that the Company does not regain compliance by April 22, 2024 the Company may be eligible for an additional 180-day period to regain compliance. The receipt of the Notification Letter has no immediate effect on the listing of the Company's shares, which will continue to trade uninterrupted on NASDAQ under the ticker "VEV". The Company will monitor the closing price for its common stock during the compliance period and intends to take all reasonable measures available to regain compliance under the NASDAQ Listing Rules and to maintain the listing of its common stock on the Nasdaq Capital Market.

08:41 EDT Gladstone Investment supports SFEG in acquisition of Climax - Gladstone Investment Corporation continued its support of portfolio company Specialized Fabrication Equipment Group with additional debt and equity capital to support its acquisition of CPMT Holdings Corp., and subsidiaries, including Climax Portable Machine Tools. Headquartered in Newberg, Oregon, Climax is a leading designer and manufacturer of portable machine tools, welding systems, and valve testing and repair systems. The products are used for non-discretionary, on-site, high-precision machining of critical infrastructure assets and equipment.

08:39 EDT Ascent Solar achieves power milestone of 1900 W/kg at AM0 using CIGS tech - Ascent Solar Technologies announced its latest CIGS technology has achieved a measured Specific Power of 1900 W/kg at AM0. Specific Power refers to the power-to-weight ratio for a system or component, specifically watts per kilogram. The Specific Power rate is the most important factor for solar applications where overall array mass is crucial, including those in the Aerospace sector, where the cost per kilogram is between 2-25k dollars to launch payloads into low earth orbit/ Higher energy orbits such as geosynchronous equatorial orbit or cislunar space typically run an order of magnitude more per kg, with payloads intended for moon landing having been booked for over $1 Million/kg.

08:38 EDT LanzaTech forms JV with Olayan Financing Company in Saudi Arabia - LanzaTech Global and Olayan Financing Company have formed a joint venture company in the Kingdom of Saudi Arabia to accelerate the commercial deployment of LanzaTech's carbon recycling technology in hard-to-abate industries within the Kingdom. The joint venture will deploy and develop projects utilizing LanzaTech's carbon recycling technology within KSA and selectively across the broader Middle East. Focusing on a region with strong decarbonization goals, this partnership intends to enable LanzaTech to deploy its commercial technology more quickly and broadly across multiple sectors using a range of waste carbon feedstocks, including waste industrial gases and solid waste feedstocks. It will also explore opportunities to further develop projects that are fully integrated with the LanzaJet Alcohol-to-Jet process to produce sustainable aviation fuel. The newly formed joint venture company will bring decarbonization solutions to multiple customers and asset owners within KSA and the broader Middle East, enabled by LanzaTech's platform.

08:36 EDT Foresight receives notice of allowance for 3D image analysis system patent - Foresight Autonomous Holdings has received a notice of allowance from the U.S. Patent and Trademark Office for its patent application, number 17/982,691, for "System and Method for Stereoscopic Image Analysis." The patented technology enables the generation of 3D depth perception from any given pair of cameras, even those that have different optical properties and fields of view. This capability allows for flexible cameras positioning on vehicles, and also enables vehicle manufacturers to leverage different existing cameras that could not previously be used for depth perception. This technology improves obstacle detection and enhances understanding of road conditions for advanced driver-assistance system or autonomous driving. The patented technology includes a method for automatic calibration of cameras and a computationally efficient method for calculating dense depth maps. This technology transforms a pair of cameras and a processor into a high frequency and accurate depth sensor. This patent serves as the underlying technology of Foresight's Mono2Stereo and Mono2Stereo 360 perception enhancement solutions. The Mono2Stereo and Mono2Stereo 360 solutions enhance existing vision sensor systems by using proprietary software-based algorithms to create 3D and 360 3D perception, respectively. These solutions are designed to amplify the performance of existing ADAS sensors resulting in better distance accuracy and more robust active safety features.

08:34 EDT HUMBL announces exchange of debt for preferred stock - HUMBL exchanged approximately $6.5M in debt for 8,775 shares of Series C Preferred Stock. The exchange was consummated with Sartorii, LLC, HUMBL's largest creditor. The exchange was completed as part of a concerted effort to reduce the company's outstanding debt. During the calendar year 2023, HUMBL has retired over $28M in debt.

08:33 EDT Akebia announces FDA accepted resubmission of NDA for vadadustat - Akebia Therapeutics announced the FDA has acknowledged that the resubmission to its New Drug Application, or NDA, for vadadustat as a treatment for anemia due to chronic kidney disease, or CKD, in adult patients on dialysis, was complete. The FDA has classified this as a class 2 response, which results in a six-month review period from the date of resubmission, and the FDA set a user fee goal date of March 27, 2024. Akebia's resubmission to its NDA addressed the issues raised in the complete response letter. The filing included post-marketing safety data from tens of thousands of patients in Japan where vadadustat is approved and has been on the market for more than three years. Vadadustat is currently approved for use in 35 countries.

08:32 EDT Inspira Technologies granted U.S. patent for INSPIRA ART500 device - Inspira Technologies announced the grant of an additional patent by the U.S. Patent and Trademark Office for its respiratory medical device, the INSPIRA ART500. The newly granted patent relates to a novel automated self-priming module designed for the INSPIRA ART500 device. This unique innovative operating module further expands the INSPIRA ART500 advancement to potentially ensure patient safety with a proprietary built-in self-automated priming module aimed to ensure an emboli-free connection to the patient's vascular system, thereby potentially reducing risks of the formation of clots that reduces blood flow. The patent consists of nine distinct claims, all deemed novel with inventive merit and practical applicability. In addition to the United States, the company has initiated patent applications in Europe and several countries in other regions.

08:24 EDT Navigator Holdings, Yara invest into Azane Fuel Solutions - Yara Growth Ventures, the venture investment arm of Yara International ASA (YARIY), and Navigator (NVGS) announced that they have each successfully acquired a 14.5% interest in the Norwegian startup Azane Fuel Solutions AS. Subject to customary conditions, Azane intends to build the world's first ammonia bunkering network, with Yara Clean Ammonia already pre-ordering 15 units from Azane. The investment made by Yara and Navigator is expected to enable Azane to begin construction of its first bunkering unit for ammonia supply in Norway, aiming to kickstart the transition to zero-carbon fuels for maritime transportation. Future value creation for Azane is expected to come through international expansion with its bunkering solutions and broadening of its offerings in ammonia fuel handling technology. Mads Peter Zacho, Chief Executive Officer, Navigator, stated: "Green ammonia is crucial to the future success of carbon free shipping, and Azane is working to provide a solution to a clear and important gap in the ammonia fuel value chain. Global ammonia demand is expected to triple by 2050, with a significant part being for ship fuel. In an increasingly strong regulatory environment towards greener fuels in the shipping industry, I am very pleased Navigator is not only making efforts to become a more sustainable business itself, but also investing in scale-ups that we believe can support and expedite the transition across our industry. We look forward to strengthening our working relationships with Yara and Azane through this partnership."

08:21 EDT PetVivo received favorable responses from veterinarians for Spryng - PetVivo Holdings announced it received a very favorable response from veterinarians regarding the Company's innovative product Spryng, with OsteoCushion technology at the American College of Veterinary Surgeons conference held on October 11th to October 14th, 2023 in Louisville, Kentucky. Two presentations at the ACVS Conference heightened the enthusiastic interest in veterinarians to learn more about Spryng and consider its use in their practices. Finally, the Company released the completed results of a clinical study conducted by Ethos Veterinary Health at the ACVS annual conference; the clinical study examined the benefit and tolerability of an intra-articular injection of a collagen-elastin biomaterial into the stifle joint of dogs with suspected cruciate ligament rupture. The clinical study results demonstrated that there were significant improvements in all of the primary and secondary clinical variables throughout the study period. In summary, this study demonstrated that Spryng is a reasonable, non-invasive alternative for patients with cranial cruciate disease) when patient and/or owner factors preclude surgical intervention.

08:19 EDT Accenture TD Bank unveil coalition with disability, IN to advance inclusion - Accenture (ACN), a leading global professional services company, and TD Bank (TD), announced the formation of a cross-industry coalition of Chief Marketing Officers CMO and Chief Communications Officers CCO powered by Disability:IN, a leading global organization driving disability inclusion and equality in business. The coalition aims to accelerate disability inclusion across the marketing and communications professions at large by delivering on six shared objectives. Coalition members include CMOs and CCOs from Disability:IN's partner companies such as Adobe, Experian and SAP.

08:18 EDT Safety Shot announces second U.S. patent issued for JW-700 - Safety Shot announced the U.S. Patent and Trademark Office has issued Patent No. US 11,766,392 for JW-700, a topical treatment designed to improve minoxidil's efficacy, marking a significant milestone in the development of treatments for androgenetic alopecia, or hair loss. This is the second U.S. patent issued for JW-700 this year and adds to the growing global IP estate for Safety Shots Legacy products. This issued patent discloses composition and methods for inducing the expression of sulfotransferases in hair follicles and expands patent protection on JW-700's new formulation. An ongoing clinical study of JW-700 in India was recently completed and is now in the final stages of analysis. "This new, broader U.S. patent, encompassing new formulations, is a crucial component of Safety Shot's ongoing pursuit of the $1.5 billion minoxidil hair loss market. Following its launch in India in July of 2023, sales of MinoxiBoost have exceeded all expectations and we expect our distribution partners will continue to deliver robust sales," stated Safety Shot's CEO Brian John. "The recently completed clinical trial is a vital next step to support a full launch of JW-700 in the U.S. and other key markets. We look forward to reporting data in the coming weeks as well as the launch of this incredible product in the USA."

08:16 EDT Telus achieves ISO 31700-1 Privacy By Design certification - The company said, "TELUS has marked a historic milestone by becoming the first company in the world to achieve the ISO 31700-1 Privacy by Design certification. This achievement substantiates TELUS' commitment to safeguarding privacy and advancing the principles of trustworthy data practices across Canada and beyond."

08:15 EDT Aspira Women's announces poster on miRNA-based ovarian cancer test - Aspira Women's Health announced that a poster on an in-development miRNA-based ovarian cancer test was presented at the AACR Special Conference in Cancer Research: Ovarian Cancer, held on October 5, 2023 in Boston, MA. The test is expected to be launched as a part of the Company's OvaSuite portfolio in collaboration with a consortium of world-renowned academic researchers under a previously announced licensing agreement. The study showed the addition of miRNA improved the detection of early-stage ovarian cancers, and that diagnostic performance improved even further when using a combination of approaches, including miRNA, proteins and metadata. The data suggest that using combined approaches could improve the triaging of patients with suspected ovarian cancers. Nicole Sandford, President and Chief Executive Officer of Aspira Women's Health said, "We are very pleased to see such promising initial findings from our collaboration with the Dana-Farber Cancer Institute. The analysis shows the potential for improving ovarian cancer diagnostics by combining our trusted technology with miRNA. It is exactly findings like these that give us hope that one day we will be able to detect ovarian cancer before it has progressed to its deadliest stages."

08:13 EDT Shift4 Payments partners with Zero Hash to build one stop fiat, crypto solution - Zero Has announced that Shift4, an Integrated Payments and Commerce Technology platform, has leveraged Zero Hash's full-stack API to build a fiat-to-crypto on-ramp for web3 merchants. Highlights: Shift4 has embedded Zero Hash's turnkey crypto infrastructure to offer web3 merchants a one stop fiat and crypto solution; Shift4 has leveraged Zero Hash's customer identity-verification-as-a-service to safely and compliantly onboard users to crypto services; Shift4 uses Zero Hash's full API stack to enable merchants to embed and customize a fiat-to-crypto on-ramp, natively into their checkout flow.

08:12 EDT Rani Therapeutics announces preclinical data on RaniPill platform - Rani Therapeutics announced preclinical data supporting the safety and tolerability of the RaniPill drug delivery platform following 60-day repeat administration. In the 60-day good laboratory practices study in healthy animals, the RaniPill(R) capsule was well-tolerated with no treatment-related adverse events. "The preclinical data announced today are highly encouraging and we believe these data further validate the safety and tolerability of our RaniPill(R) drug delivery platform," said Mir Hashim, PhD, Chief Scientific Officer of Rani. "Our platform has the potential to offer an oral delivery option for drugs otherwise only available as injections and is drug-agnostic with the opportunity for application across a wide range of biologics. The data from this 60-day GLP study further bolster the safety database supporting the RaniPill(R) capsule and enable the launch of longer-term clinical trials of Rani's pipeline programs, including our Phase II study of RT-102 for osteoporosis which we plan to initiate in 2023." The preclinical GLP study evaluated the safety and tolerability of the RaniPill drug delivery platform, following 60-day repeat oral administration of the test article, RT-100. RT-100 was well-tolerated with no treatment-related adverse events and all animals remained clinically healthy throughout the study.

08:11 EDT Enviri's Clean Earth recycled 8.7B pounds of waste in 2022 - Clean Earth, a division of Enviri Corporation, increased recycling of hazardous and non-hazardous waste by 53% last year, according to the Company's newly released Environmental, Social, and Governance report. Clean Earth recycled 8.7 billion pounds of waste in 2022, including hazardous and non-hazardous waste, contaminated soil, dredge material, universal waste, and e-waste. Clean Earth doubled the amount of non-hazardous waste it recycled and increased the amount of hazardous waste it recycled by 41%. The Company increased the amount of wastewater it recycled by 84%. "Clean Earth is proud of the fact that we recycled the equivalent of almost two million cars last year, ensuring that we are reusing and repurposing hazardous, non-hazardous, and contaminated waste rather than landfilling it," said Jeff Beswick, President of Clean Earth. "We are transforming the world's largest waste streams into valuable recycling opportunities, helping support a circular economy and benefiting our planet and future generations. While we are proud of our progress, we understand this is a journey and will continue to expand and enhance our capabilities while making the world cleaner and greener."

08:07 EDT Immutep receives A$1,134,882 R&D tax incentive - Immutep Limited announces that it has received a A$1,134,882 cash rebate from the Australian Federal Government's R&D tax incentive program. The cash rebate provided in respect of expenditure incurred on eligible R&D activities conducted in the 2022 fiscal year, mainly related to the Company's TACTI-002 and TACTI-003 clinical study using its lead compound eftilagimod alpha, conducted in Australia. Immutep also receives the French CIR tax incentive through its subsidiary Immutep S.A.S in respect of expenditure incurred on eligible R&D activities conducted in the European Union. Immutep will apply the non-dilutive funding towards furthering its current active clinical trial programs for its lead product candidate, efti. The expected cash reach of the Company extends into early calendar year 2026.

08:06 EDT Xiao-I appoints Fangzhen Lin as Chief Scientific Advisor - Xiao-I announced the appointment of Professor Fangzhen Lin as its Chief Scientific Advisor. Professor Lin, a globally recognized scientist and authority in the AI field, will provide invaluable momentum to Xiao-I's ongoing technological advancements. Lin holds an exceptional academic background, currently serving as a Professor in the Department of Computer Science and Engineering at the Hong Kong University of Science and Technology and a fellow at the Association for the Advancement of Artificial Intelligence. His research expertise focuses on AI cognition and reasoning. He earned a bachelor's degree in software from Fuzhou University in 1983, a master's degree in AI from Peking University in 1986, and a Ph.D. in AI from Stanford University in 1991. Additionally, he has chaired or been a member of program committees for several top international conferences in the AI field.

08:05 EDT Nuvve Holding and Blue Bird replace Martinsville ISD's diesel fleet - Nuvve Holding (NVVE) and Blue Bird (BLBD) have replaced the Martinsville Independent School District's, or ISD, diesel fleet with five Blue Bird Vision electric buses, five Nuvve Level II chargers and the innovative AI-powered Nuvve FleetBox 2.0 charge management software. Martinsville ISD Principal Keith Kimbrough commented: "We're a small district but proud to be leading the way on sustainable and clean commutes for Texas school children." Kimbrough secured a $1.58M Clean School Bus grant from the U.S. Environmental Protection Agency in October 2022 to help underwrite the project. He also partnered with Rush Truck Centers as dealer, Blue Bird for the fleet and Nuvve K-12 to consult and provide the right chargers and software for the district's routes and daily charging needs.

08:05 EDT Ryder announces two new share repurchase programs - Ryder announced its board of directors has authorized two new share repurchase programs. Under the new discretionary repurchase program, Ryder management is authorized to repurchase up to 2M shares of common stock, at its discretion, from October 12 through October 12, 2025. This program is designed to provide management with capital structure flexibility while concurrently managing objectives related to balance sheet leverage, acquisition opportunities, and shareholder returns. Our previously authorized 2M share discretionary repurchase program, authorized in February , was completed in September. Under the new anti-dilutive repurchase program, Ryder management is authorized to repurchase up to 2M shares of common stock from October 12, through October 12, 2025, that have been issued to employees under the company's employee stock plans since August 31. This program is designed to mitigate the dilutive impact of shares issued under the company's employee stock plans. The new program replaced the company's 2021 anti-dilutive program, which expired on October 14.

07:47 EDT Jacobs selected by Harris County METRO's transit program - Jacobs has been selected as Owner's Advisor for the Metropolitan Transit Authority of Harris County's, or METRO, Joint Development and Transit Oriented Development program in Houston, Texas. METRO selected Jacobs as part of a county-wide initiative to leverage its regional transit properties with private investment to increase ridership, enhance the transit experience and improve connectivity for Houston's 2.3M residents. Jacobs will provide comprehensive consulting for planning and real estate management services to meet METRO's mobility and development needs. METRO is currently developing a Joint Development framework to move forward with significant development opportunities at multiple Harris County METRO properties. Jacobs teams with local firms including The Goodman Corporation, Jones Lang LaSalle, Outreach Strategists, Isani and Winstead for comprehensive Houston-area real estate, development expertise, and stakeholder engagement, comprising a trusted Houston-based team.

07:43 EDT Northern Oil and Gas sees Q3 DD&A rate 14.20 - $14.25 per Boe. - For the third quarter, the DD&A rate is expected to be $14.20 - $14.25 per Boe. The increase to the DD&A rate versus the second quarter is primarily driven by the closing of the Novo acquisition in the third quarter, and is in line with prior expectations. The Company enters into derivative agreements to hedge a portion of its commodity pricing exposure and makes mark-to-market fair value adjustments each quarter to the unrealized value of its unsettled commodity derivative portfolio. For the third quarter of 2023, mark-to-market losses on unsettled commodity derivatives are estimated to be approximately $205 million. Total net gains on settled commodity derivatives for the third quarter are estimated to be approximately $5M. Since its second quarter earnings release, NOG has added hedges for approximately 2.4 MMBoe of oil and 10.9 MMBtu of natural gas in the form of puts, costless collars and swaps for Q4-2023 through 2026, in addition to region-specific basis hedges. "As we enter the fourth quarter, we continue to focus capital on growth opportunities for next year and beyond," commented Nick O'Grady, NOG's CEO. "Our singular focus remains on executing on high return opportunities. In keeping with our practice, we have used recent commodity price strength to layer in additional oil and natural gas hedges, along with additional basis hedges, to protect our underwritten returns as we deploy capital." "We had significant, counter-seasonal success in the Ground Game, especially early in the third quarter when oil prices were significantly lower," commented Adam Dirlam, NOG's President. "These projects should, at today's pricing, deliver significantly higher returns than we originally underwrote. Additionally, we've seen notable increases in our Permian well proposal activity as commodity prices have improved. All of this points to increased growth prospects for 2024 and beyond."

07:35 EDT OptimizeRx announces completion of Medicx acquisition - OptimizeRx announced it has successfully completed its acquisition of Healthy Offers, dba Medicx Health. The two companies will operate independently through 2023 with full integration during the first quarter of 2024. With the closing of the Medicx acquisition, the Company will expand its executive team with the addition of Medicx's President, Theresa Greco, becoming the Chief Commercial Officer of OptimizeRx. Steve Silvestro will step into a new role as President, leading all aspects of corporate strategy and daily business management. No other leadership changes will occur at the executive level.

07:33 EDT Papa John's announces limited return of Shaq-a-Roni pizza in Caada - Papa Johns announced the limited-time return of its popular Shaq-a-Roni pizza in Canada, developed in partnership with board member, franchisee and former basketball superstar, Shaquille O'Neal. The extra-large pizza with a purpose is back for its fourth year. Today through December 31st, 2023, $1 from every Shaq-a-Roni sold will go to the Canadian food rescue program Second Harvest. Every dollar will supply three healthy meals to people and agencies in need.

07:32 EDT Boeing still expects to deliver 70-80 787s - Now expects to deliver 375-400 737 airplanes.

07:31 EDT Boeing backs FY23 operating cash flow $4.5B-$6.5B; free cash flow $3B-$5B

07:10 EDT Green Thumb Industries to open RISE Dispensary in Florida - RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries, announced that RISE Dispensary Sun City Center, the Company's tenth retail location in Florida and 86th nationwide, will open on October 27th. "As we near five years of caring for medical cannabis patients in Florida, we are excited to expand our presence to ten locations in the state with the opening of RISE Sun City Center," said Green Thumb President Anthony Georgiadis. "Our team is passionate about building strong relationships with the communities we serve, and we look forward to supporting Minorities for Medical Marijuana as part of our new store opening charity donation tradition."

07:09 EDT BioXcel announces positive findings from independent third party audit - BioXcel Therapeutics announced positive findings from an independent third party audit of the data from a single site in its TRANQUILITY II Phase 3 trial. Conducted by a well-regarded regulatory and quality consulting firm, the independent audit consisted of a comprehensive review of records from over 50% of subjects enrolled at the single trial site to identify any additional instance of misconduct or fraud and to evaluate data integrity and reliability for eligibility, safety, and efficacy data. This sample size provides 95% confidence that the data reviewed is a representative sample. Following an extensive review, the team of auditors did not identify any findings that they believe impact the data reliability or integrity, nor did they find any evidence of additional misconduct or fraud. Based on these findings, BioXcel Therapeutics believes that the positive, statistically significant TRANQUILITY II trial data announced in June 2023 potentially support a supplemental new drug application for BXCL501 for the acute treatment of agitation associated with dementia in probable Alzheimer's disease.

07:07 EDT Lantronix announces expansion of embedded product line - Lantronix announced the expansion of its embedded product line to support the evolving needs of the automotive industry. Based on Qualcomm Technologies' latest generation of Snapdragon Ride and Cockpit Platforms, including the latest Snapdragon Ride Flex Platform, Lantronix's new Snapdragon Ride SX Automotive Development Platform is designed to enable the rapid creation of customizable infotainment, cluster and driver monitoring systems.

07:06 EDT Talisker signs ore sale LOI for Bralorne Gold Project with New Gold - Talisker Resources announced that the Company has signed a non-binding LOI with New Gold to enter into an ore purchase agreement in respect of Talisker's Bralorne Gold Project. The parties will use commercially reasonable efforts to diligently and in good faith negotiate and enter the Ore Purchase Agreement whereby New Gold proposes to purchase up to 300,000 tonnes of ore from the Project to process at the mill located at its New Afton Mine.

07:01 EDT General Dynamics reports Q3 net cash from operations $1.3B

06:59 EDT T-Mobile narrows FY23 adjusted EBITDA view to $29B-$29.2B from $28.9B-$29.2B - Postpaid net customer additions are expected to be between 5.7 million and 5.9 million, an increase from prior guidance of 5.6 million to 5.9 million. Core Adjusted EBITDA, which is Adjusted EBITDA less lease revenues, is expected to be between $29.0 billion and $29.2 billion, an increase from prior guidance of $28.9 billion to $29.2 billion. Merger synergies are expected to be approximately $7.5 billion. Merger-related costs are expected to be approximately $1.0 billion before taxes. These costs are excluded from Core Adjusted EBITDA but will impact Net income, Net cash provided by operating activities and Adjusted Free Cash Flow. Net cash provided by operating activities, including payments for Merger-related costs, is expected to be between $18.3 billion and $18.5 billion, an increase from prior guidance of $18.0 billion to $18.3 billion. Cash purchases of property and equipment, including capitalized interest, are expected to be between $9.6 billion and $9.8 billion, an increase from the prior guidance of $9.5 billion to $9.7 billion. Adjusted Free Cash Flow, including payments for Merger-related costs, is expected to be between $13.4 billion and $13.6 billion, an increase from prior guidance of $13.2 billion to $13.6 billion. Adjusted Free Cash Flow guidance does not assume any material net cash inflows from securitization

06:49 EDT Universal Stainless & Alloy appoints Christopher Zimmer as CEO - Universal Stainless & Alloy Products announced that it has taken the next step in its leadership succession plan with the naming of Christopher M. Zimmer as President and CEO. Zimmer has also been appointed to the Board of Directors. The transition is effective November 1st. Zimmer succeeds Dennis M. Oates in those roles. Oates takes on the newly-established role of Executive Chairman of Universal. Zimmer is a 15-year veteran of Universal. He joined the Company in 2008 as Vice President of Sales and Marketing, became Executive Vice President and Chief Commercial Officer in 2014, and assumed the post of COO in April 2023. As COO, he has been responsible for manufacturing, technology, and quality organizations as well as sales, marketing and supply chain management and development.

06:42 EDT MSC Industrial sees FY24 ADS flat to up 5% - Sees FY24 tax rate 25%-25.5%. Sees FY24 adjusted operating margin 12%-12.8%. Gershwind concluded, "Looking ahead, we are excited about the next chapter in our Mission Critical journey. We are focused on continuing to outgrow the IP Index by four hundred basis points or more and producing incremental margins of at least 20% through a cycle. Doing so allows us to pursue our longer-term aspiration of mid-teens operating margins and ROIC north of 20%."

06:36 EDT MarketAxess reaffirms FY23 CapEx view $52.0M-$58.0M - Based on the progression of operating expenses and the acquisition of Pragma, which closed on October 2, the Company is refining its previously stated FY23 expense guidance range of $418.0M-$446.0M, to a new range of $432.0M-$438.0M. The new range includes an estimated $12.5M of M&A related expenses, including $8.5M of direct operating expenses related to Pragma and $4.0M of non-recurring M&A expenses. The Company is reconfirming its FY23 capital expenditures guidance range of $52.0M-$58.0M. The Company now expects the FY23 effective tax rate to be approximately 23.5%, below the previously stated range of 25.0%-26.0%. The lower effective tax rate for the year is mainly driven by favorable apportionment in connection with state tax filings and other federal tax filing positions.

06:34 EDT Terran Orbital awarded $4.7M contract by European Space Agency - Terran Orbital announced its wholly-owned international subsidiary, Tyvak International s.r.l., has been chosen as a prime contractor under a $4.7M contract by the European Space Agency for a proximity operations and in-orbit servicing mission that will deploy a nanosatellite spacecraft from Space Rider, the European uncrewed robotic laboratory.

06:30 EDT Taylor Morrison sees Q4 home closings 2,950 - Sees Q4 average closing price $615.000. Sees Q4 ending active community count 320-325. Sees Q4 effective tax rate 25%.

06:23 EDT Deutsche Bank aims for operational efficiencies of EUR 2.5B annually by 2025 - Deutsche Bank aims for incremental operational efficiencies of EUR 2.5B annually, predominantly by 2025. Key initiatives are largely running in line with or ahead of plan, headcount reduction measures in senior non-client-facing staff have been completed and further workforce efficiency measures are in place. Further measures underway include streamlining front-to-back processes and optimization of the distribution network; the number of branches has been reduced by 93 in the first nine months of 2023.

05:51 EDT Nvidia says U.S. implemented new export curbs on AI chips ahead of schedule - Nvidia said in a regulatory filing on Tuesday night that on October 23, the U.S. Government informed the company, that the licensing requirements of the interim final rule entitled "Implementation of Additional Export Controls: Certain Advanced Computing Items; Supercomputer and Semiconductor End Use; Updates and Corrections," dated October 18, 2023, applicable to products having a "total processing performance" of 4800 or more and designed or marketed for datacenters, is effective immediately, impacting shipments of the company's A100, A800, H100, H800, and L40S products. These licensing requirements were originally to be effective after a 30-day period, Nvidia said. Given the strength of demand for the company's products worldwide, the company does not anticipate that the accelerated timing of the licensing requirements will have a near-term meaningful impact on its financial results, it added.

05:45 EDT Freeline announces new data from GALILEO-1 trial of FLT201 - Freeline announced that new clinical data from its ongoing Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus, or AAV, gene therapy candidate for Gaucher disease, show a substantial reduction of glucosylsphingosine levels in the blood of the first patient treated with FLT201. Lyso-Gb1 is a well-established biomarker of clinical response in Gaucher disease, with reductions in lyso-Gb1 correlating with positive clinical outcomes. These data are being highlighted in an oral presentation at the European Society of Gene & Cell Therapy, or ESGCT, 30th Annual Congress held in Brussels, Belgium. The presentation at ESGCT will include updated data on safety, tolerability, and GCase activity, as well as new data on lyso-Gb1, hemoglobin and platelet levels, from the first two patients dosed in GALILEO-1, a first-in-human, international, multicenter Phase 1/2 dose-finding study in people with Gaucher disease Type 1. Both patients were treated with a dose of 4.5x1011 vg/kg and have successfully come off their prior therapies. A third patient was dosed in the same cohort earlier this month; only safety, tolerability and liver transaminase data were available for patient 3 as of the data cutoff. As of the October 13 data cutoff, the data demonstrated: Favorable safety and tolerability, with no infusion reactions and no serious adverse events as of 16 weeks post-dosing for patient 1, nine weeks post-dosing for patient 2, and one week post-dosing for patient 3. All treatment-related adverse events were mild and resolved without intervention. Alanine-transaminase, or ALT, and aspartate-transaminase, or AST, levels remained in the normal range for all patients during the same time periods. Robust increases in plasma GCase levels. Patient 1 showed an approximately 700-fold increase over baseline to more than 70 micromol/L/h as of 12 weeks post-dosing. Patient 2 showed a similarly robust response, with an approximately 450-fold increase over baseline to more than 40 micromol/L/h as of six weeks post-dosing. Normal plasma GCase levels range from 0.3 to 1.2 micromol/L/h. Normalization of leukocyte GCase activity, indicating cellular uptake of GCase. Leukocyte GCase activity reached normal levels in patient 1 and patient 2 within four weeks of dosing and remained normal through week 14 and week 8, respectively. Leukocytes are validated markers for broad cellular uptake in Gaucher disease. Reduction in DBS lyso-Gb1 levels in patient 1 to approximately 60 ng/mL as of 12 weeks post-dosing from more than 100 ng/mL at the patient's initial assessment. Only one post-dosing assessment was available for patient 2 as of the data cutoff. Patients 1 and 2 had normal hemoglobin levels at baseline and have remained in the normal range at each weekly assessment, including those taken after coming off enzyme replacement therapy or substrate replacement therapy.

05:39 EDT Tradeweb Markets, FTSE Russell announce strategic partnership - Tradeweb Markets and FTSE Russell, an LSEG business, announced a strategic partnership to develop the next generation of fixed income index pricing and index trading products.

05:29 EDT Shenandoah to acquire Horizon Telecom for $385M - Shenandoah announced it has entered into a definitive agreement to acquire 100% of the equity interests in Horizon Acquisition Parent for $385M. Consideration will consist of $305M in cash and $80M of Shentel common stock. Horizon is a commercial fiber provider in Ohio and adjacent states serving national wireless providers, carriers, enterprises, and government, education and healthcare customers. Horizon's 7,200 route-mile fiber network is the largest and most dense network across its footprint with over 9,000 on-net locations. Approximately 64% of Horizon's revenues are derived from their commercial customers. Based in Chillicothe, Ohio, Horizon was founded in 1895 as the incumbent local exchange carrier in Ross County, Ohio and rapidly expanded its fiber network over the past 14 years. Most recently, Horizon has pursued a strategy of investing in Fiber-to-the-Home in tier 3 & 4 markets in Ohio and currently passes 14,000 homes and businesses with fiber in its ILEC market and 18,000 homes in new, greenfield markets adjacent to its commercial fiber network. The transaction is subject to certain regulatory approvals and other customary closing conditions and is expected to close in the first half of 2024. The purchase price, less present value of tax benefits, represents:12.9x 2022 Horizon adjusted EBITDA multiple net of synergies and approximately $51,000 per fiber route mile. Shentel intends to fund the transaction with a combination of existing cash resources, revolving credit facility capacity and an amended and upsized credit facility. The company has received $275M in financing commitments from CoBank, Bank of America, Citizens Bank, N.A., and Fifth Third Bank, N.A..GCM Grosvenor, a selling unit holder of Horizon, will exchange its equity interest in Horizon for 4.08M shares of Shentel common stock with an aggregate value of $80M based on a reference price of $19.604 resulting in GCM owning approximately 7% of Shentel's fully diluted common shares after the transaction is closed. Shentel has entered into a 7% participating exchangeable perpetual preferred stock investment agreement with Energy Capital Partners, or ECP, an existing Shentel shareholder and long-time infrastructure investor, to provide $81M of growth capital to fund the FTTH network expansion, the government grant projects and general corporate purposes. The dividend can be paid in cash or in-kind at the option of the company. The preferred stock can be exchanged for Shentel common stock at an exchange price of $24.50, a 25% premium to the reference price of $19.604, under certain conditions as outlined in the investment agreement. This financing is expected to close in conjunction with the transaction. The company plans to raise additional growth capital for the FTTH network expansion, Government Grant Projects and general corporate purposes, which may include exploring strategic alternatives for its tower portfolio.